US 11484591
Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites
granted A61KA61K2039/505A61K31/167
Quick answer
US patent 11484591 (Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K31/167, A61K31/565, A61K31/74